Cargando…

HLA-dependent tumour development: a role for tumour associate macrophages?

HLA abnormalities on tumour cells for immune escape have been widely described. In addition, cellular components of the tumour microenvironment, in particular myeloid derived suppressor cells (MDSC) and alternatively activated M2 tumour-associated macrophages (TAMs), are involved in tumour promotion...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marchesi, Maddalena, Andersson, Emilia, Villabona, Lisa, Seliger, Barbara, Lundqvist, Andreas, Kiessling, Rolf, Masucci, Giuseppe V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856519/ https://www.ncbi.nlm.nih.gov/pubmed/24093459 http://dx.doi.org/10.1186/1479-5876-11-247

Ejemplares similares

Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis
por: Andersson, Emilia, et al.
Publicado: (2015)

Stereotactic Ablative Radio Therapy (SABR) followed by immunotherapy a challenge for individualized treatment of metastatic solid tumours
por: Masucci, Giuseppe V, et al.
Publicado: (2012)

Role of HLA-G in Viral Infections
por: Jasinski-Bergner, Simon, et al.
Publicado: (2022)

The role of tumour-associated macrophages in bone metastasis
por: Sousa, Sofia, et al.
Publicado: (2016)

Tumour-associated macrophages: versatile players in the tumour microenvironment
por: Ji, Zoey Zeyuan, et al.
Publicado: (2023)

Distribution of Photofrin between tumour cells and tumour associated macrophages.
por: Korbelik, M., et al.
Publicado: (1991)

Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cells
por: Kiessling, Rolf, et al.
Publicado: (2012)

The Rôle of the Large Peritoneal Macrophage in Tumour Homograft Rejection
por: Hartveit, F.
Publicado: (1964)

Urokinase and macrophages in tumour angiogenesis.
por: Hildenbrand, R., et al.
Publicado: (1995)

Intense tumour-cell destruction by syngeneic mice: role of macrophages, complement activation and tumour-cell factors.
por: Orbach-Arbouys, S., et al.
Publicado: (1977)

Competition between foetal tissue and macrophage-dependent natural tumour resistance.
por: Keller, R.
Publicado: (1979)

CIITA methylation and decreased levels of HLA-DR in tumour progression
por: Iizuka, N, et al.
Publicado: (2004)

PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates
por: Pico de Coaña, Yago, et al.
Publicado: (2020)

A role for immunotherapy: preventing macrophage anergy in the tumour environment
por: Elia, Androulla, et al.
Publicado: (2013)

Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models
por: Belgiovine, Cristina, et al.
Publicado: (2017)

Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma
por: Maximov, Victor, et al.
Publicado: (2019)

Endothelial extracellular vesicles promote tumour growth by tumour‐associated macrophage reprogramming
por: Njock, Makon‐Sébastien, et al.
Publicado: (2022)

Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment
por: Zheng, Xiang, et al.
Publicado: (2020)

Tumour macrophages as potential targets of bisphosphonates
por: Rogers, Thea L, et al.
Publicado: (2011)

Molecular Repolarisation of Tumour-Associated Macrophages
por: van Dalen, Floris J., et al.
Publicado: (2018)

TLR Signaling and Tumour-Associated Macrophages
por: Colegio, Oscar R., et al.
Publicado: (2011)

The role of the tumour microenvironment in the angiogenesis of pituitary tumours
por: Marques, Pedro, et al.
Publicado: (2020)

The Role of CDK5 in Tumours and Tumour Microenvironments
por: Do, Phuong Anh, et al.
Publicado: (2020)

HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
por: van den Ingh, H. F., et al.
Publicado: (1987)

Reply: CIITA methylation and decreased levels of HLA-DR in tumour progression
por: Morimoto, Y, et al.
Publicado: (2004)

No evidence for seasonal variations of the incidence of testicular germ cell tumours in Germany
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2023)

Modulation of actin dynamics as potential macrophage subtype-targeting anti-tumour strategy
por: Pergola, Carlo, et al.
Publicado: (2017)

Collagen production by macrophages in tumour encapsulation and dormancy.
por: Vaage, J., et al.
Publicado: (1991)

Impact of tumour associated macrophages in pancreatic cancer
por: Mielgo, Ainhoa, et al.
Publicado: (2013)

Macrophage-Mediated Subversion of Anti-Tumour Immunity
por: Quaranta, Valeria, et al.
Publicado: (2019)

The tumour microenvironment creates a niche for the self-renewal of tumour-promoting macrophages in colon adenoma
por: Soncin, Irene, et al.
Publicado: (2018)

Chimeric antigen receptor macrophage therapy for breast tumours mediated by targeting the tumour extracellular matrix
por: Zhang, Wenlong, et al.
Publicado: (2019)

HLA-DR antigens on differentiating human mammary gland epithelium and breast tumours.
por: Bártek, J., et al.
Publicado: (1987)

Soluble HLA in the Aqueous Humour of Uveal Melanoma Is Associated with Unfavourable Tumour Characteristics
por: Wierenga, Annemijn P. A., et al.
Publicado: (2019)

Possible role of macrophage-like suppressor cells in the anti-tumour activity of BCG.
por: Castés, M., et al.
Publicado: (1981)

The role of tumour-derived iNOS in tumour progression and angiogenesis
por: Kostourou, V, et al.
Publicado: (2011)

Roles of Farnesyl-Diphosphate Farnesyltransferase 1 in Tumour and Tumour Microenvironments
por: Ha, Nguyen Thi, et al.
Publicado: (2020)

Activated macrophages promote Wnt signalling through tumour necrosis factor-α in gastric tumour cells
por: Oguma, Keisuke, et al.
Publicado: (2008)

Tumour-To-Tumour Metastasis
por: Salm, R.
Publicado: (1975)

Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen or tumour derived synthetic peptides
por: Moro, Monica, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_ucp1ivac1kfoksm970tcsqglk9